Prof Ian Campbell
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
197 Scholarly works
37 Projects
HIGHLIGHTS
2026
Journal article
Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profiles
DOI: 10.1038/s41523-025-00884-y2026
Journal article
Investigating the contribution of rare non-coding variants in BRCA1, BRCA2 and PALB2 to hereditary breast cancer.
DOI: 10.1038/s41523-026-00942-z2021
Research grants (ARC, NHMRC, MRFF)
Genetic Mosaicism as a Stable and Robust Blood DNA Biomarker for Precision Risk Assessment for Cancer
2020
Research Grant
Integrative Approaches to Identifying the Causes of Familial Breast Cancer
2018
Research Grant
The Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer (Kconfab)
2014
Journal article
Inferring copy number and genotype in tumour exome data
DOI: 10.1186/1471-2164-15-7322012
Journal article
CONTRA: Copy number analysis for targeted resequencing
DOI: 10.1093/bioinformatics/bts146
RECENT SCHOLARLY WORKS
2026
Journal article
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
DOI: 10.1016/j.breast.2025.1046192026
Journal article
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification
DOI: 10.1016/j.ebiom.2026.1061992026
Journal article
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU study
DOI: 10.1002/bcp.704312025
Journal article
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
DOI: 10.1038/s41525-025-00529-w2025
Journal article
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer
DOI: 10.1038/s41431-025-01786-02025
Journal article
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2
DOI: 10.1200/JCO.24.001762024
Journal article
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
DOI: 10.1038/s41597-024-03869-x2024
Journal article
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
DOI: 10.1158/1078-0432.CCR-23-3552